Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NeoAdjuvant Chemotherapy Versus Surgery Alone After Stent Placement for Left-sided Obstructive Colonic Cancer:a Multicenter, Controlled, Open-label Clinical Trial (NACSOC Trial)

NCT02972541 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.

NCT NCT02972541
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02972541 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NeoAdjuvant Chemotherapy Versus Surgery Alone After Stent Placement for Left-sided Obstructive Colonic Cancer:a Multicenter, Controlled, Open-label Clinical Trial (NACSOC Trial)
Lead sponsor
Beijing Chao Yang Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
September 30, 2016
Completion date
December 30, 2023
Enrollment
248 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, neoadjuvant chemotherapy, obstruction, stent